[Federal Register Volume 89, Number 120 (Friday, June 21, 2024)]
[Notices]
[Pages 52090-52092]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13611]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical Technology Enterprise Consortium
Notice is hereby given that, on April 2, 2024, pursuant to section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Medical Technology Enterprise
Consortium (``MTEC''), has filed written notifications simultaneously
with the Attorney General and the Federal Trade Commission disclosing
changes in its membership. The notifications were filed for the purpose
of extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, 10x National Security, Aldie, VA; 4WEB, Inc., Frisco, TX;
Abram Scientific, Inc., South San Francisco, CA; Admetsys Corp.,
Boston, MA; Advanced RNA Vaccine Technologies, Inc., North Bethesda,
MD; Aergility Corp., Dunnellon, FL; Airway Shield S.L., Santander
Cantabria, Spain; AmacaThera, Inc., Toronto, CANADA; Ampel LLC,
Charlottesville, VA; Anthos Group, Inc., Torrance, CA; Apos US
Management, Inc., New York, NY; Asynchealth, Pebble Beach, CA; Baebies,
Inc., Durham, NC; Best Practice Associates LLC dba Tria Federal,
Arlington, VA; Bio-Change, Ltd., Yokneam, ISRAEL; Black Fur Biomedical,
Tucson, AZ; Blue Spark Technologies, Inc., Westlake, OH; Board of
Regents, Nevada System of Higher Education on behalf of the University
of Nevada, Las Vegas, Las Vegas, NV; Board of the Trustees of the
Colorado School of Mines, Golden, CO; Cadet NM, Inc., Albuquerque, NM;
Cambridge Research & Development, Inc., Nashua, NH; Canaery, Alachua,
FL; Coldplasmatech GmbH, Greifswald, GERMANY; ComeBack Mobility, Inc.,
New York, NY; CoolSpine LLC, Woodbury, CT; Cristae Consulting LLC,
Moorestown, NJ; Directed Systems, Ltd., Cambridge, UNITED KINGDOM;
Eluciderm, Inc., San Diego, CA; ExThera Medical Corp., Martinez, CA;
EyeYon Medical, Ltd., Ness Ziona, ISRAEL; Florida Institute of
Technology, Melbourne, FL; FluidForm, Inc., Waltham, MA; Gigantor
Technologies, Inc., Melbourne Beach, FL; Global Virtual Training LLC,
New York, NY; GoodCap Pharmaceuticals, Toronto, CANADA; Hatch Product
Development LLC, Waukegan, IL; Henley Ion LLC, New Orleans, LA; Idea
Meds, Inc., New York, NY; Immense Dynamics, Inc., Bremerton, WA;
Innovative Health Sciences LLC, Chester, NY; Innovosens AB, Inc.,
Wilmington, DE; Interoperability Institute LLC, Lansing, MI; JustBard
Technologies LLC, Brunswick, MD; KaloCyte, Inc., Baltimore, MD; LaCire
LLC, Alexandria, VA; Lankenau Institute for Medical Research,
Wynnewood, PA; Loma Linda University, Loma Linda, CA; Lucid Reality
Labs LLC, Miami, FL; LumaFlo, Inc., Detroit, MI; Lundquist Institute
for Medical Innovation at Harbor-UCLA Medical Center, Torrance, CA;
Medasense Biometrics, Ltd., Ramat Gan, ISRAEL; MediCarbone, Inc.,
Tuscon, AZ; Mitochon Pharmaceuticals, Inc., Blue Bell, PA; Modular
Matter, Inc., Abingdon, MD; Moonrise Medical, Inc., Oakville, CANADA;
Noleus Technologies, Inc., Houston, TX; Nou Systems, Inc., Huntsville,
AL; Noxy Health Products, Inc., Anaconda, MT; Oak Grove Technologies,
Raleigh, NC; Obsidian Solutions Group, Fredericksburg, VA; Omniox,
Inc., San Francisco, CA; Osetomics LLC, Glen Mills, PA; Osteolyse,
Inc., Soda Springs, CA; Owl Therapeutics, San Antonio,
[[Page 52091]]
TX; PathKeeper Surgical, Ltd., Kfar Saba, ISRAEL; PyrAmes, Inc.,
Cupertino, CA; Qidni Labs, Inc., Buffalo, NY; Rafa Laboratories, Ltd.,
Jerusalem, ISRAEL; ReBlood Rx LLC, San Diego, CA; Regerna Therapeutics,
Inc., New York, NY; Regulatory Quality Management Information Source,
Inc., Amesbury, MA; Remedor Biomed Ltd., Nof Hagalil, ISRAEL; Renovera,
PBC, West Lafayette, IN; Respair, Inc., Pittsburgh, PA; RevBio, Inc.,
Lowell, MA; Rion, Inc., Rochester, MN; Saforax Health, Haifa, ISRAEL;
SCHOTT North America New Ventures, Duryea, PA; SenseVOC LLC, Littleton,
CO; Serda B.V., Amsterdam, THE NETHERLANDS; SMSbiotech, Inc., San
Marcos, CA; Stanford University, Stanford, CA; STEER Tech LLC,
Annapolis Junction, MD; Synapstim Ltd., Herzliya, ISRAEL; Temple
University--Of The Commonwealth System of Higher Education,
Philadelphia, PA; The Hospital for Special Surgery Fund, Inc., New
York, NY; The Institute for Integrative and Innovative Research at the
University of Arkansas, Fayetteville, Fayetteville, AK; Tietronix
Software, Inc., Houston, TX; TYBR Health, Inc., Houston, TX; Unit
Medical Devices, Ltd., Sderot, ISRAEL; University of Arkansas, Little
Rock, Little Rock, AR; University of Cincinnati, Cincinnati, OH;
Valiant Harbor International LLC, Bethesda, MD; Vasomune Therapeutics
US, Inc., Raleigh, NC; Velico Medical, Inc., Beverly, MA; ViBo Health,
Inc., Los Angeles, CA; Videra Health, Inc., Orem, UT; Vir
Biotechnology, San Francisco, CA; ViyaMD, Inc., Marina del Rey, CA;
Western Michigan University Homer Stryker M.D. School of Medicine,
Kalamazoo, MI; and XO Armor Technologies, Inc., Auburn, AL have been
added as parties to this venture.
Also, 2C4 Technologies, Inc., San Antonio, TX; AbViro LLC,
Bethesda, MD; Acer Therapeutics, Inc., Newton, MA; Advanced Surgical
Retractor Systems, Inc., Shavano Park, TX; Allied Technologies and
Consulting LLC, Frederick, MD; Amend Surgical, Inc., Alachua, FL;
American Military Families Action Network, Tacoma, WA; American Type
Culture Collection, Manassas, VA; AMK Technologies of Ohio LLC, Mount
Vernon, OH; Anchor Therapy Clinic, Sacramento, CA; Applied Research
Center, Aiken, SC; Arcascope, Inc., Arlington, VA; Aruna Bio, Inc.,
Athens, GA; Asante Bio, Tampa, FL; Atorvia Health Technologies, Inc.,
Ottawa, Ontario, CANADA; Avel eCare LLC, Sioux Falls, SD; Axioforce,
Inc., St. Louis, MO; Bio1 Systems, Inc., San Carlos, CA; BioAge Labs,
Inc., Richmond, CA; Biobeat Technologies, Ltd., Petach Tikva, ISRAEL;
Bionet Sonar, Inc., Burlington, MA; BiotechPharma Corp., Severna Park,
MD; Board of Trustees of the University of Illinois, Champaign, IL;
Bodies Done Right, Mayfield Village, OH; California Service Dog
Academy, Visalia, CA; Capital Factory Properties LLC, Austin, TX;
Channel Clinical Solutions LLC, Raleigh, NC; Children's Hospital Los
Angeles, Los Angeles, CA; ClearCoast USA LLC, St. Petersburg, FL;
Concurrent Technologies Corp., Johnstown, PA; Conseqta Technology,
Arlington, VA; Continuous Precision Medicine, Research Triangle Park,
NC; CSP Technologies, Inc., Auburn, AL; CTD Group LLC, Vashon, WA;
Daxor Corp., Oak Ridge, TN; Decisive Point Group, Beacon, NY;
DermiSense, Inc., Richmond, VA; DHR Health Institute for Research and
Development, Edinburg, TX; Dog Tag Buddies, Billings, MT; D-Prime LLC,
McLean, VA; Drexel University, Philadelphia, PA; Eagle Global
Scientific LLC, San Antonio, TX; Endoluxe, Inc., Dunwoody, GA;
Endomedix, Inc., Montclair, NJ; Engineering & Computer Simulations,
Inc., Orlando, FL; Entasis Therapeutics, Waltham, MA; FireFlare Games
LLC, Cheyenne, WY; Float Lab Technologies, Inc., Venice, CA; Foothold
Labs, Inc., Olathe, KS; Gel4Med, Lowell, MA; GelMEDIX, Inc., Newton,
MA; GelSana Therapeutics, Inc., Aurora, CO; Global Resonance
Technologies LLC, Shelburne, VT; Grand Valley State University, Grand
Rapids, MI; Hafion, Inc., Ann Arbor, MI; Hope 4 You Global LLC, Lowell,
AR; Hubly, Inc. dba Hubly Surgical, Evanston, IL; Human Systems
Integration, Inc., East Walpole, MA; Icahn School of Medicine at Mount
Sinai, New York, NY; ICON Government and Public Health Solutions,
Hinckley, OH; Idion, Inc., Darien, CT; iFyber LLC, Ithaca, NY; Incell
Corp. LLC, San Antonio, TX; IOTAI, Inc., Fremont, CA; Jana Care, Inc.,
Watertown, MA; JC3 LLC, Rockbridge Baths, VA; Joint Research and
Development, Inc., Stafford, VA; Jurata Thin Film, Inc., Chapel Hill,
NC; K9s for Warriors, Ponte Vedra Beach, FL; KBR, Beavercreek, OH;
Kerecis, Ltd., Isafjordur, ICELAND; Longhorn Vaccines and Diagnostics
LLC, Bethesda, MD; Lynntech, Inc., College Station, TX; Manzanita
Pharmaceuticals, Inc., Woodside, CA; Maravai Life Sciences, San Diego,
CA; MCPC, Cleveland, OH; Mechano Therapeutics LLC, Philadelphia, PA;
MediView XR, Inc., Cleveland, OH; Medtronic, Minneapolis, MN; MeMed US,
Inc., Milpitas, CA; Methodist Hospital Research Institute dba Houston
Methodist Research Institute, Houston, TX; Microbion Corp., Bozeman,
MT; Milestone Scientific, Inc., Roseland, NJ; MiMedx Group, Inc.,
Marietta, GA; Muscle Activation Techniques, Englewood, CO; MVK
Pharmaceuticals LLC, Indianapolis, IN; My Buddies Place, Inc.,
Pasadena, CA; Nakamir, Inc., Palo Alto, CA; Neurotrauma Sciences LLC,
Alpharetta, GA; New York University School of Medicine, New York, NY;
nFlux, Inc., Palm Springs, CA; NightHawk Biosciences, Inc.,
Morrisville, NC; Nihon Kohden OrangeMed, Inc., Santa Ana, CA; North
Carolina Biotechnology Center, Research Triangle Park, NC; NovoPedics,
Inc., Princeton, NJ; Nyrada, Inc., Gordon, AUSTRALIA; Odic, Inc.,
Littleton, MA; Omnicure, Inc., Ladue, MO; Oregon Biomedical Engineering
Institute, Inc., Wilsonville, OR; OrganaBio LLC, South Miami, FL;
Orthoforge, Inc., East Grand Rapids, MI; Otter Cove Solutions LLC,
Gaithersburg, MD; Pacific Institute for Research and Evaluation,
Beltsville, MD; Padagis US LLC, Allegan, MI; Palantir USG, Inc., Palo
Alto, CA; PathoGene, Inc., Monrovia, CA; Paxauris LLC, Phoenix, AZ;
Phagelux, Inc., Montr[eacute]al, CANADA; Philips North America LLC,
Cambridge, MA; Population Sleep LLC, Dallas, TX; PortaVision Medical
LLC, Jefferson, LA; ppx-TEC LLC, Jackson, MS; Precision Trauma LLC,
Columbus, GA; Problem Solutions LLC, Johnstown, PA; Prohuman
Technologies, Concord, NC; Promethean LifeSciences, Inc., Pittsburgh,
PA; Purdue University, West Lafayette, IN; Red One Medical Devices LLC,
Savannah, GA; Regenerative Processing Plant LLC, Tampa, FL; Regranion
LLC, Mt. Pleasant, SC; Renerva LLC, Pittsburgh, PA; Resilient
Lifescience, Inc., Pittsburgh, PA; Reveille Group, Tampa, FL; Rock West
Composites, Inc., San Diego, CA; RST-Sanexas, Las Vegas, NV; SafeBeat
Rx, Inc., Chico, CA; SafeBVM Corp., Boston, MA; Safeguard Surgical,
Tampa, FL; Safi Biotherapeutics, Inc., Cambridge, MA; Saint Barnabas
Medical Center, Livingston, NJ; Saint Louis University, St. Louis, MO;
Sanofi Pasteur, Swiftwater, PA; Scientific & Biomedical Microsystems
LLC, Glen Burnie, MD; SeaStar Medical, Inc., Denver, CO; Securisyn
Medical LLC, Highlands Ranch, CO; Senseye, Inc., Austin, TX; Shee
Atik[aacute] Enterprises, Huntsville, AL; Sherpa 6, Inc., Littleton,
CO; Shipcom Federal Solutions LLC, Belcamp, MD; SLSCO, Ltd., Galveston,
TX; Softox Solutions AS, Fornebu, Norway; Soliyarn, Belmont, MA; Sophic
Synergistics LLC, Houston, TX; Sparta Biomedical, Inc., Chatham, NJ;
SPEAR Human Performance, Inc., Sandy
[[Page 52092]]
Springs, GA; SpineThera, Inc., Plymouth, MN; Steadman Philippon
Research Institute, Vail, CO; Stellarray, Inc., Austin, TX; Sterogene
Bioseparations, Inc., Carlsbad, CA; TechEn, Inc., Milford, MA; Terasaki
Institute for Biomedical Innovation, Los Angeles, CA; Texas A&M
University, College Station, TX; Texas Research & Technology
Foundation, San Antonio, TX; The Emmes Company LLC, Rockville, MD; The
Research Institute of the McGill University Health Centre, Montreal,
CANADA; TiER1 Performance Solutions, Covington, KY; Transom Scopes,
Inc. dba Instrument Technology, Inc., Westfield, MA; Trustees of the
University of Pennsylvania, Philadelphia, PA; UCHU Biosensors, Inc.,
Newark, NJ; University of Miami, Coral Gables, FL; University of
Southern California, Los Angeles, CA; U-Smell-It LLC, Guilford, CT;
Vaxxas, Cambridge, MA; Viele Exploratory Sustainable Solutions LLC,
Livingston Manor, NY; Virion Therapeutics LLC, Newark, DE; Weinberg
Medical Physics, Inc., North Bethesda, MD; Westat, Inc., Rockville, MD;
Xheme, Inc., Newton, MA; Xomix, Ltd., Chicago, IL; and ZeSa LLC, Eden
Prarie, MN have withdrawn as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MTEC intends to file additional
written notifications disclosing all changes in membership.
On May 9, 2014, MTEC filed its original notification pursuant to
section 6(a) of the Act. The Department of Justice published a notice
in the Federal Register pursuant to section 6(b) of the Act on June 9,
2014 (79 FR 32999).
The last notification was filed with the Department on January 9,
2024. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on February 6, 2024 (89 FR 8246).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-13611 Filed 6-20-24; 8:45 am]
BILLING CODE P